NEWS
Print Your Certificate
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! The 2025 Edition of the AD Scientific Index is now live!
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
"Exciting Update! The 2025 Edition of the AD Scientific Index is now live!
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
Sylvie Boyer
i
INSERM - Paris / France
Economics & Econometrics / Economics
AD Scientific Index ID: 4420404
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Sylvie Boyer's MOST POPULAR ARTICLES
1-)
Dolutegravir-based or low-dose efavirenz–based regimen for the treatment of HIV-1NAMSAL ANRS 12313 Study GroupNew England Journal of Medicine 381 (9), 816-826, 20192392019
2-)
Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trialCC Iwuji, J Orne-Gliemann, J Larmarange, E Balestre, R Thiebaut, ...The lancet HIV 5 (3), e116-e125, 20182372018
3-)
The point-of-care laboratory in clinical microbiologyM Drancourt, A Michel-Lepage, S Boyer, D RaoultClinical microbiology reviews 29 (3), 429-447, 20161522016
4-)
Non-adherence to antiretroviral treatment and unplanned treatment interruption among people living with HIV/AIDS in Cameroon: Individual and healthcare supply-related factorsS Boyer, I Clerc, CR Bonono, F Marcellin, PC Bilé, B VentelouSocial science & medicine 72 (8), 1383-1392, 20111362011
5-)
Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open …A Calmy, TT Sanchez, C Kouanfack, M Mpoudi-Etame, S Leroy, ...The lancet HIV 7 (10), e677-e687, 20201342020
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept